Table 3.

Changes in body composition after the administration of ipragliflozin in patients with type 2 diabetes

	Baseline	12 weeks	p values
Body fat (%)	31.9 ± 5.5	31.1 ± 5.9	0.024
Non-fat mass in upper extremities (kg)	4.7 (3.8–5.2)	4.7 (3.6–5.1)	0.903
Non-fat mass in lower extremities (kg)	12.4 (11.2–13.8)	12.6 (11.4–13.6)	0.799
Android (kg)	2.0 (1.7–4.4)	1.8 (1.6–2.1)	0.013
Gynoid (kg)	2.6 (2.2–7.2)	2.3 (2.0–2.4)	0.009
Total fat mass (kg)	18.6 (17.3–20.6)	18.2 (16.7–19.5)	0.004
Total non-fat mass (kg)	41.4 (37.2–43.3)	41.1 (36.5–43.3)	0.241
Skeletal muscle index	6.50 (6.19–6.74)	6.49 (6.01–6.70)	0.386